Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

Background: Data from previous work suggests that there is no correlation between systemic (plasma) paclitaxel exposure and efficacy in patients treated for esophageal cancer. In this trial, we investigated ATP-binding cassette efflux transporter expression and intratumoral pharmacokinetics of pacli...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ruben A. G. van Eerden, Leni van Doorn, Femke M. de Man, Niels Heersche, Michail Doukas, Thierry P. P. van den Bosch, Esther Oomen-de Hoop, Peter de Bruijn, Sander Bins, Eman Ibrahim, Suzan Nikkessen, Lena E. Friberg, Stijn L. W. Koolen, Manon C. W. Spaander, Ron H. J. Mathijssen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
tissue pharmacokinetics
intratumoral
paclitaxel
pharmacokinetics
esophageal cancer
ABCB1
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/2da8bb17075a4bb7a21f579be94bb87f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/2da8bb17075a4bb7a21f579be94bb87f

Ejemplares similares